142 related articles for article (PubMed ID: 29054474)
1. Deubiquitylating enzymes as cancer stem cell therapeutics.
Haq S; Suresh B; Ramakrishna S
Biochim Biophys Acta Rev Cancer; 2018 Jan; 1869(1):1-10. PubMed ID: 29054474
[TBL] [Abstract][Full Text] [Related]
2. Regulation of pluripotency and differentiation by deubiquitinating enzymes.
Suresh B; Lee J; Kim H; Ramakrishna S
Cell Death Differ; 2016 Aug; 23(8):1257-64. PubMed ID: 27285106
[TBL] [Abstract][Full Text] [Related]
3. Deubiquitinating enzymes in cancer stem cells: functions and targeted inhibition for cancer therapy.
Kaushal K; Antao AM; Kim KS; Ramakrishna S
Drug Discov Today; 2018 Dec; 23(12):1974-1982. PubMed ID: 29864528
[TBL] [Abstract][Full Text] [Related]
4. Targeting Deubiquitinating Enzymes in Glioblastoma Multiforme: Expectations and Challenges.
Jin WL; Mao XY; Qiu GZ
Med Res Rev; 2017 May; 37(3):627-661. PubMed ID: 27775833
[TBL] [Abstract][Full Text] [Related]
5. Concise Review: Fate Determination of Stem Cells by Deubiquitinating Enzymes.
Chandrasekaran AP; Suresh B; Kim HH; Kim KS; Ramakrishna S
Stem Cells; 2017 Jan; 35(1):9-16. PubMed ID: 27341175
[TBL] [Abstract][Full Text] [Related]
6. The bad seed gardener: Deubiquitinases in the cancer stem-cell signaling network and therapeutic resistance.
Qiu GZ; Sun W; Jin MZ; Lin J; Lu PG; Jin WL
Pharmacol Ther; 2017 Apr; 172():127-138. PubMed ID: 27919796
[TBL] [Abstract][Full Text] [Related]
7. Activity Based Profiling of Deubiquitylating Enzymes and Inhibitors in Animal Tissues.
McLellan L; Forder C; Cranston A; Harrigan J; Jacq X
Methods Mol Biol; 2016; 1449():411-9. PubMed ID: 27613053
[TBL] [Abstract][Full Text] [Related]
8. Deubiquitylation of deubiquitylases.
Haq S; Ramakrishna S
Open Biol; 2017 Jun; 7(6):. PubMed ID: 28659380
[TBL] [Abstract][Full Text] [Related]
9. Overlapping genes may control reprogramming of mouse somatic cells into induced pluripotent stem cells (iPSCs) and breast cancer stem cells.
Mosca E; Cocola C; Sabour D; Pelucchi P; Bertalot G; Palumbo O; Carella M; Götte M; Schöler HR; Reinbold R; Zucchi I; Milanesi L
In Silico Biol; 2010; 10(5-6):207-21. PubMed ID: 22430355
[TBL] [Abstract][Full Text] [Related]
10. Targeting deubiquitinating enzymes in cancer stem cells.
Lei H; Shan H; Wu Y
Cancer Cell Int; 2017; 17():101. PubMed ID: 29142505
[TBL] [Abstract][Full Text] [Related]
11. Deubiquitinating enzymes as cancer biomarkers: new therapeutic opportunities?
Poondla N; Chandrasekaran AP; Kim KS; Ramakrishna S
BMB Rep; 2019 Mar; 52(3):181-189. PubMed ID: 30760385
[TBL] [Abstract][Full Text] [Related]
12. Cancer stem cells - A therapeutic target?
Maitland NJ; Collins AT
Curr Opin Mol Ther; 2010 Dec; 12(6):662-73. PubMed ID: 21154158
[TBL] [Abstract][Full Text] [Related]
13. Application of Cancer Cell Reprogramming Technology to Human Cancer Research.
Pan XY; Tsai MH; Wuputra K; Ku CC; Lin WH; Lin YC; Kishikawa S; Noguchi M; Saito S; Lin CS; Yokoyama KK
Anticancer Res; 2017 Jul; 37(7):3367-3377. PubMed ID: 28668824
[TBL] [Abstract][Full Text] [Related]
14. Functional analysis of deubiquitylating enzymes in tumorigenesis and development.
Cheng J; Guo J; North BJ; Wang B; Cui CP; Li H; Tao K; Zhang L; Wei W
Biochim Biophys Acta Rev Cancer; 2019 Dec; 1872(2):188312. PubMed ID: 31449841
[TBL] [Abstract][Full Text] [Related]
15. Evolving Strategies for Therapeutically Targeting Cancer Stem Cells.
Talukdar S; Emdad L; Das SK; Sarkar D; Fisher PB
Adv Cancer Res; 2016; 131():159-91. PubMed ID: 27451127
[TBL] [Abstract][Full Text] [Related]
16. Autophagic homeostasis is required for the pluripotency of cancer stem cells.
Sharif T; Martell E; Dai C; Kennedy BE; Murphy P; Clements DR; Kim Y; Lee PW; Gujar SA
Autophagy; 2017 Feb; 13(2):264-284. PubMed ID: 27929731
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNAs in normal and pathological pluripotency.
Häfner SJ; Talvard TG; Lund AH
Semin Cell Dev Biol; 2017 May; 65():1-10. PubMed ID: 27438587
[TBL] [Abstract][Full Text] [Related]
18. Reprogramming of retinoblastoma cancer cells into cancer stem cells.
Yue F; Hirashima K; Tomotsune D; Takizawa-Shirasawa S; Yokoyama T; Sasaki K
Biochem Biophys Res Commun; 2017 Jan; 482(4):549-555. PubMed ID: 27856246
[TBL] [Abstract][Full Text] [Related]
19. Side population and cancer stem cells: therapeutic implications.
Moserle L; Ghisi M; Amadori A; Indraccolo S
Cancer Lett; 2010 Feb; 288(1):1-9. PubMed ID: 19523754
[TBL] [Abstract][Full Text] [Related]
20. Reprogramming and Stemness.
Laplane L
Perspect Biol Med; 2015; 58(2):229-46. PubMed ID: 26750604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
